Related Experiment Video
Updated: Oct 15, 2025

Isolation and Identification of Extravascular Immune Cells of the Heart
Published on: August 23, 2018
Myocarditis in the Setting of Recent COVID-19 Vaccination
Laura Onderko1, Benjamin Starobin1, Amy E Riviere1
1Cardiovascular Disease Service Line, Maine Medical Center, Portland, Maine, USA.
Abstract:
We report three patients who presented with chest pain after receiving either the BNT162b2 Pfizer/BioNTech or mRNA-1273 Moderna/NIH vaccine. Clinical presentation, biomarker, and cardiac MRI supported myocarditis. It is imperative that potential side effects of COVID-19 vaccine are reported to improve our knowledge about COVID-19 and mRNA vaccines.
More Related Videos
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis IV: Nursing Management
Pericarditis I: Introduction
Pericarditis III: Medical Management

